CRNX
Crinetics Pharmaceuticals, Inc.
$36.80
AlphaVal Unavailable
AlphaVal: CRNX has had negative net income and negative EPS in all 5 available fiscal year(s). Quality gate: persistently unprofitable companies are excluded.